Nestlé using AI to build food products for weight loss drug users
Nestlé is deploying artificial intelligence and nutritional science to develop a line of products aimed at the millions…
Roche outlays $2.3bn for Hanmi’s non-GLP-1 obesity candidate
Roche has conducted its joint-largest deal of the year so far, licensing a clinical-stage UCN2 (urocortin-2) analog being…
Nestlé Is Developing New Products for Weight Loss Drug Users as GLP-1 Drugs Change How People Eat
When Ozempic and Wegovy became household names, food companies had an obvious reason to worry. If people were…
Nestlé targets GLP-1 users with new nutrition and beauty-from-within products
THE WHAT? Nestlé is developing products specifically for consumers using GLP-1 weight-loss drugs, targeting nutritional and appearance-related effects…
Nestlé Wants to Turn the GLP-1 Threat into an Opportunity
Nestlé Wants to Turn the GLP-1 Threat into an Opportunity – Moby THE GIST Our analysts just identified…
Roche unveils strategy to become ‘top 3’ obesity company
Roche has set its sights on becoming a “top three” obesity company, according to the pharma’s long-awaited strategy…
Zealand’s Zupreme serves up to 10.7% mean weight loss
Zealand Pharma’s Roche-partnered amylin analog demonstrated “placebo-like tolerability” and up to 10.7% mean weight loss at 42 weeks…
Roche’s obesity ambition not reliant on one megablockbuster
When Roche unveiled its long-awaited obesity strategy yesterday, it included a bold goal of becoming one of the…
ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ option
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
Roche obesity drug helps patients shed 22.7% of weight in mid-stage trial
By Maggie Fick June 5 (Reuters) – Roche said on Friday that patients lost 22.7% of their body…
Swiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss
Novo Nordisk, the Danish pharma giant, has seen its fortunes reach astronomical heights since its drugs, Ozempic and…
Roche’s Enicepatide: A Game-Changer in the Obesity Drug Race
Roche, the Swiss pharmaceutical giant, announced on Friday that its experimental obesity drug, Enicepatide, has achieved significant weight…